Duquesne Family Office »

Silence Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.4M 387k 19.00
2024-03-31 $8.4M 387k 21.60

More positions owned by Duquesne Family Office

Coherent Corp (COHR)
Coupang Cl A (CPNG)
Vistra Energy (VST)
Natera (NTRA)
Philip Morris International (PM)
Seagate Technology Hldngs Pl Ord Shs (STX)
Microsoft Corporation (MSFT)
Woodward Governor Company (WWD)
Kinder Morgan (KMI)
Mid-America Apartment (MAA)
Zoominfo Technologies Common Stock (ZI)
Teck Resources CL B (TECK)
Camden Ppty Tr Sh Ben Int (CPT)
Flutter Entmt SHS (FLUT)
MercadoLibre (MELI)

View all positions for Duquesne Family Office

Top funds holding Silence Therapeutics

TCG Crossover Management
Artal Group
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Millennium Management
Cormorant Asset Management
Ikarian Capital
Aquilo Capital Management
5AM Venture Management
Duquesne Family Office
SG Americas Securities

View all funds holding Silence Therapeutics